Vascular dementia: A critical review of diagnosis and treatment;Demencia vascular: Dificuldades diagnosticas e tratamento

Arquivos de Neuro-Psiquiatria

Volumn 56, Issue 3 A, 1998, Pages 498-510

  André, Charles ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Cerebral ischemia, prevention and control; Dementia vascular, diagnosis; Dementia vascular, drug therapy; Dementia vascular, rehabilitation

Indexed keywords

CENTRAL STIMULANT AGENT; DENBUFYLLINE; DIHYDROERGOTOXINE MESILATE; FLUVOXAMINE; NEUROPROTECTIVE AGENT; NIMODIPINE; OXIRACETAM; PENTOXIFYLLINE; PIRACETAM; PROPENTOFYLLINE; PYRITINOL;

CAREGIVER; CEREBROVASCULAR DISEASE; COGNITION; DIAGNOSTIC ACCURACY; HUMAN; HUMAN CELL; HUMAN TISSUE; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGICAL TEST; REVIEW; STROKE; TREATMENT PLANNING; DISEASE COURSE;

DEMENTIA, VASCULAR; DISEASE PROGRESSION; HUMANS;

EID: 0031852920     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x1998000300025     Document Type: Review

References (83)

1. Aharon-Peretz J, Masiah A, Pillar T, Epstein R, Tzischinsky O, Lavie P Sleep-wake cycles in multi-infarct dementia and dementia of the Atzheimer type Neurology 1991;41:1616-1619
2. Alessi CA. Managing the behavioral problems of dementia in the home. Clin Geriat Med 1991;7:787-801.
3. Amar K, Wilcock GK, Scott M. The diagnosis of vascular dementia in the light of the new criteria. Age Ageing 1996;25:51-55.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 4.Ed Washington: RR Donnelly & Sons, 1994:133-155.
5. Banki CM, Karrnacsi L, Bisserte G, Nemeroff CB. Cerebrospinal fluid neuropeptides in mood disorder and dementia J Affect Dis 1992;25:39-45.
6. Black RS, Barclay LL, Nolan KA, Thaler HT, Hardiman ST, Blass JP. Pentoxifylline in cerebrovascular dementia. J Am Geriat Soc 1992;40:237-244.
7. Borten J, Lodder J, Kessels F. Two clinically distinct lacunar entities? A hypothesis. Stroke 1993;24:652-656
8. Bottini G, Vallar G, Cappa S, et al Oxiracetan in dementia: a double-blind, placebo-controlled study Acta Neurol Scand 1992;86:237-241.
9. Broderick JP, Narayan S, Gaskill M, Dhawan AP, Khoury J. Volumetric measurement of multifocal brain lesions: implications for treatment trials of vascular dementia and multiple sclerosis. J Neuroimaging 1996;6:36-43.
10. Brooks WM, Wesley MH, Kodituwakku PW, Garry PJ, Rosenberg GA 1H-MRS differentiates white matter hyperintensities in subcortical arteriosclerosic encephalopathy from those in normal elderly. Stroke 1997;28:1940-1943.
11. Cacabelos R, Franco-Maside A, Alvarez XA. Interleukin-1 in Alzheimer's disease and multi-infarct dementia, neuropsychological correlations Meth Find Experim Clin Pharmacol 1991;13:703-708.
12. Cacabelos R, Fernandez-Novoa L, Perez-Trullen JM, Franco-Maside A, Alvarez XA. Serum histamine in Alzheimer's disease and multi-infarct dementia. Meth Find Experim Clin Pharmacol 1992;14:711-715
13. Cacabelos R, Alvarez XA, Franco-Maside A, Fernandez-Novoa L, Caamano J. Effect of CDP-Choline on cognition and immune function in Alzheimer's disease and multi-infarct dementia Ann N Y Acad Sci 1993;695:321-323.
14. Cacabelos R, Alvarez XA, Franco-Maside A, Fernandez-Novoa L, Caamano J. Serum tumor necrosis factor (TNF) in Alzheimer's dissease and multi-infarct dementia. Met Find Experim Clin Pharmacol 1994;16:29-35
15. Casby JA, Holm MB: The effect of music on repetitive disruptive vocalizations of persons with dementia. Am J Occupat Ther 1994;48:883-889.
16. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992;42:473-480.
17. Corso EA, Campo G, Triglio A, Napoli A, Lanaia F Prevalence of moderate and severe Alzheimer dementia and multi-infarct dementia in the population of southeastern Sicily. Ital J Neurol Sci 1992;13:215-219.
18. Cummings JL Subcortical dementia as a manifestation of cerevrovascular disease. New Issues Neurosci 1992;4:151-158
19. Dabic-Jeftic M, Mikula I. Auditory end visual event-related potencials in patients suffering from Alzheimer's dementia and multiinfarct dementia, before and after treatment with piracetam. Funct Neurol 1993;8:335-345
20. DeReuck J, Decoo D, Strijckmans K, Lemahieu I Does the severity of leukoaraiosis contribute to senile dementia? A comparative computerized and positron emission tomographic study Eur Neurol 1992;32:199-205.
21. Dierckx RA, Vandewoude M, Saerens J, et al. Sensitivity and specificity of 99Tcm-HMPAO single-headed SPECT in dementia. Nucl Med Communie 1993;14:792-797.
22. Dunbabin DW, Sandercock PAG Preventing stroke by the modification of risk factors. Stroke 1990;21(Suppi IV):36-39.
23. Dunkin JJ, Leuchter AF, Newton TF, Cook IA Reduced EEG coherence in dementia: state or trait marker? Biol Psychiatry 1994;35:870-879.
24. Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau A Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol Neurosurg Psychiatr 1988; 51:1037-1044.
25. Fischer P, Jellinger K, Gatterer G, Danielczyk W Prospective neuropathological validation of Hachinski's ischaemic score in dementias. J Neurol Neurosurg Psychiatry 1991;54:580-583.
26. Fischhof PK , Saletu B, Ruther E, Litschauer G, Moslinger-Gehmayr R, Herrmann WM Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type and multi-infarct dementia. Neuropsychobiology 1992;26:65-70.
27. 2+ homeostasis in dementia Meth Find Experim Clin Pharmacol 1993;15:549-555.
28. Friedman R, Gryfe CI, Tal DT, Freedman M. The noisy elderly patient: prevalence, assessment, and response to the antidepressant doxepin. J Geriat Psychiatr Neurol 1992;5:187-191.
29. Gallai V, Mazzotta G, Firenze C, Montesi S, DelGatto F. Study of the P300 and cerebral maps in subjects with multi-infarct dementia treated with cytidine. Psychopharmacology 1991;103:1-5
30. Gorelick PB, Chatterjee A, Patel D, et al. Cranial computed tomographic observations in multi-infarct dementia: a controlled study. Stroke 1992;23:804-811.
31. Greene JA, Ingram TA, Johnson W. Group psychotherapy for patients with dementia Southern Med J 1993;86:1033-1035.
32. Gur AY, Neufeld MY, Treves TA, Aranovich BD, Bornstein NM, Korczyn AD. EEG as predictor of dementia following first stroke Acta Neurol Scand 1994;90:263-265.
33. Hachinski VC, Iliff LD, Ailhka E. Cerebral blood flow in dementia Arch Neurol 1975;32:632-637.
34. Hagnell O, Ojesjo L, Rorsman B. Incidence of dementia in the Lundby study Neuroepidemiology 1992;11(Suppl 1):61-66
35. Hanafusa H, Motomura N, Fukai M Event-related potentials in senile dementia of Alzheimer's type, multiinfarct dementia and Parkinson's disease. Japanese J Psychiatry Neurol 1991;45:667-670 (Summmary).
36. Herrmann WM, Stephan K Efficacy and clinical relevance of cognition enhancers. Alz Dis Assoc Dis 1991;5(Suppl 1):S7-S12.
37. Higashi S, Fujita M, Nishimoto Y, Asaba H, Sakai T. Neuroendocrine studies in dementia patients: responses of plasma GH and PRL following bromocriptine administration. Acta Neurol Scand 1994;90:39-44.
38. Hinrichsen GA, Niederecke G Dementia management strategies and adjustment of family members of older patients. Gerontologist 1994;34:95-102
39. Johansson A, Gustafson L Psychiatric symptoms in patients with dementia treated in a psychogeriatric day hospital. Int Psychogeriatr 1996;8:645-658
40. Kase CS. Epidemiology of multi-infarct dementia Alzh Dis Assoc Dis 1991;5:71-76.
41. Katzman R, Kawas C. The evolution of the diagnosis of dementia: past, present and future. In: Poeck K, Freund H-J, Ganshirt H (eds). Neurology. Proceedings of the XIIIth World Congress of Neurology, Hamburg, September 1-6, 1985. New York: Springer-Verlag, 1986:43-49.
42. Kurita A, Black ARS, Blass JP, Deck MD, Nolan KA. Failure of CT to detect ischemic lesions in patients with dementia. J Geriatr Psychiatry Neurol 1993;6:245-250
43. Lechner H, Schmidt R, Goetz B Long-term experience of a trial in multi-infarct dementia. Neuroepidemiology 1990;9:228-232
44. Leuchter AF, Newton TF, Cook IA, Walter DO, Rosenberg-Thompson S, Lachenbruch PA Changes in brain functional connectivity in Alzheimer-type and multi-infarct dementia. Brain 1992;115:1543-1561.
45. Leuchter AF, Dunkin JJ, Lufkin RB, Anzal Y, Cook IA, Newton TF Effect of white matter disease on functional connections in the aging brain J Neurol Neurosurg Psychiatry 1994;57:1347-1354
46. Loeb C, Gandolfo C. Diagnostic evaluation of degenerative and vascular dementia Stroke 1983;14:399-401.
47. Maeda K, Tanimoto K, Terada T, Shintani T, Kakigi T. Elevated urinary free cortisol in patients with dementia Neurobiol Aging 1991;12:161-163.
48. Martin-Loeches M, Gil P, Jimenez F, Exposito FJ, Miguel F, Cacabelos R, Rubia FJ. Topographic maps of brain electrical activity in primary degenerative dementia of the Alzheimer's type and multiinfarct dementia Biol Psychiatry 1991;29:211-223.
49. McKeith IG, Bartholomew PH, Irvine EM, Cook J, Adams R, Simpson AE. Single-photon emission computed tomography in elderly patients with Alzheimer's disease and multi-infarct dementia Regional uptake of technecium-labelled HMPAO related to clinical measurements. Br J Psychiatry 1993;163:597-603.
50. Meguro K, Doi C, Ueda M, et al. Decreased cerebral glucose metabolism associated with mental deterioration in multi-infarct dementia. Neuroradiology 1991;33:305-309
51. Meyer JS, Judd BW, Tawakina T, Rogers RL, Mortel KF. Improved cognition after control of risk factors for multi-infarct dementia JAMA 1986;256:2203-2209.
52. Mishima K, Okawa M, Hishikawa Y, Hozumi S, Hori H, Takahashi K Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia Acta Psychiatr Scand 1994;89:1-7
53. Moller HJ, Maurer I, Saletu B. Placebo-controlled trial of the xanthine derivative propentofylline in dementia. Pharmacopsychiatry 1994;27:159-165.
54. Molsa PK, Paljarvi L, Rinne JD. Validity of clinical diagnosis in vascular dementia: a prospective clinico-pathological study J Neurol Neurosurg Psychiatry 1985;48:1085-1090
55. Moroney JT, Bagiella, Desmond DW, Paik MC, Stern Y, Tatemichi TK. Risk factors for incident dementia after stroke role of hypoxic and ischemic disorders. Stroke 1996;27:1283-1289.
56. Moroney JT, Bagiella E, Tatemichi TK, Paik MC, Stern Y, Desmond DW. Dementia after stroke increases the risk of long-term stroke recurrence. Neurology 1997;48:1317-1325.
57. Nakajima M, Morimoto S, Takamoto S, et al. Endothelin-1 in cerrebrospinal fluid in elderly patients with hypertension and dementia. Hypertension 199;24:97-100.
58. Nasman B, Olsson T, Backstrom T, et al. Serum dehydroepiandrosterone sulfate in Alzheimer's disease and in multi-infarct dementia. Biol Psychiatr 1991;30:684-690.
59. Olafsson K, Jorgensen S, Jensen HV, Bille A, Arup P, Andersen J Fluvoxamine in the treatment of demented elderly patients: a double-blind, placebo-controlled study. Acta Psychiatr Scand 1992;85:453-456
60. Passeri M, Cucinotta D, Abate G, et al Oral 5′-methyltetrahydrofolic acid in senile organic mental disorders with depression: results of a double-blind multicenter study. Aging 1993;5:63-71
61. Portera-Sanchez A, DelSer T, Bermejo F, Arredondo JM. Clinical diagnosis of senile dementia of Alzheimer type and vascular dementia In Terry RD, Bills CL, Toffano G (eds) Neural aging and its implications in human neurological pathology (Aging, vol. 18) New York Raven Press, 1982;69-188.
62. Rankin ED, Haut MW, Keefover RW Clinical assessment of family caregivers in dementia Gerontologist 1992;32:813-821
63. Robichaud L, Hebert R, Desrosiers J Efficacy of a sensory integration program on behaviors of inpatients with dementia. Am J Occupat Ther 1994;48:355-360.
64. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies Report of the NINDS-AIREN International Workshop Neurology 1993;43:250-260
65. Rosen WG, Terry RD, Fuld P, Katzman R, Peck A. Pathological verification of ischemic score in differentiation of dementias Ann Neurol 1979;7:486-488
66. Rotter M, Kittner B, Rudolphi K, Rossner M, Labs KH HWA 285 (propentofylline): a new compound for the treatment of both vascular dementia end dementia of the Alzheimer type. Ann N Y Acad Sci 1996;777:404-409.
67. Saletu B, Anderer P, Fischof PK, Lorenz H, Barousch R, Bohmer F. EEG mapping and psychopharmacological studies with denbufylline in SDAT and MID Biol Psychiatry 1992;32:668-681.
68. Schmage N, Bergener M. Global rating, symptoms, behavior, and cognitive performance as indicators of efficacy in clinical studies with nimodipine in elderly patients with cognitive impairment syndromes. Internat Psychoger 1992;4(Suppl 1):89-99.
69. Schneider LS, Olin JT. Overview of clinical trials of hydergine in dementia. Arch Neurol 1994;51:787-798.
70. Semia TP, Cohen D, Paveza G, et al. Drug use patterns of persons with Alzheimer's disease and related disorders living in the community. J Am Geriatr Soc 1993;41:408-413.
71. Shen ZX, Ding Q, Wei CZ, Ding MC, Meng JM. CSF cholinesterase in early-onset and late-onset Alzheimer's disease and multi-infarct dementia of Chinese patients. Acta Neurol Scand 1993;87:19-24.
72. Shigeta M, Nishikawa Y, Shimizu M, Usui M, Hyoki K, Kawamuro Y. Horizontal component of electro-oculogram as a parameter of arousal in dementia: relationship between intellectual improvement and increasing arousal under pharmacotherapy. J Clin Pharmacol 1993;33:741-746.
73. Shimizu M. Current clinical trials of cognitive enhancers in Japan Alzh Dis Assoc Dis 1991;55(Suppl 1):S13-24.
74. Starkstein SE, Sabe L, Vazquez S, et al. Stroke 1996;27:408-414
75. Stewart JT. Managing the care of patients with dementia: how to maximize level of functioning and minimize behavior problems. Postgrad Med 1991;90:45-49
76. Tachibana H, Toda K, Sugita M, Konishi K, Matsunaga I. Computed tomographic findings in relation to event-related potentials during visual discrimination tasks in patients with multiple cerebral infarcts. Internat J Neurosci 1991;59:281-289.
77. Tatemichi TK, Paik M, Bagiella E, Desmond D. Dementia after stroke is a determinant of longterm survival (Abstract). Ann Neurol 1993;34:289.
78. Verhey FR, Lodder J, Rozendaal N, Jolles J. Comparison of seven sets of criteria used for the diagnosis of vascular dementia. Neuroepidemiology 1996;15:166-172.
79. Villardita C, Grioli S, Lomeo C, Cattaneo C, Parini J. Clinical studies with oxiracetam in patients with dementia of Alzheimer type and multi-infarct dementia of mild to moderate degree. Neuropsychobiology 1992;25:24-28
80. Wade JP Multi-infarct dementia: prevention and treatment Alz Dis Assoc Dis 1991;5:144-148.
81. Weinstein HC, Haan J, van Royen EO, et al. SPECT in the diagnosis of Alzheimer's disease and multi-infarct dementia. Clin Neurol Neurosurg 1991;93:39-43.
82. Wetterling T, Tegtmeyer KF. Serum alpha I-antitrypsin and alpha 2-macroglobulin in Aizheimer's and Binswanger's disease. Clin Invest 1994;72:196-199.
83. Wetterling T, Kanitz RD, Borgis KJ Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN) Stroke 1996;27:30-36.